Investigators: Anita Campbell, Asha Bowen, Julie Marsh
External collaborators: Steven Tong (University of Melbourne), Joshua Davis (Menzies School of Health Research), Steve Webb (Monash University), Allen Cheng (Monash University), Scott Berry (Berry Consultants)
There are an estimated 5000 episodes per year of bloodstream infections due to Staphylococcus aureus (golden staph) in Australia and an associated mortality of 20%. Despite this, there is little clinical trials evidence to guide best management. The Staphylococcus aureus Network Adaptive Platform trial (SNAP) will be a novel, large scale, international clinical trial that will both establish best practice evidence and optimise care for patients during the conduct of the trial.
SNAP-Chat is a qualitative study to recruit participants that are representative of those likely to be in the SNAP trial, to gain their insights on how to best conduct the consent process (suggested a layer approach) with potential participants. Participants who have had prior experience of staph aureus bacteremia to participate. We plan to hold four 2-hour focus groups with consumer representatives. It is estimated that four groups will be sufficient to achieve saturation of themes. Each session will last approximately 2 hours including a brief intermission and will begin with an interactive informational session (≤ 20 minutes). One of the four groups (the one based in Perth) will involve parents of children and adolescent patients who have experienced an episode of staph aureus bacteremia to determine the impact of layered consent for families participating in SNAP.
Visit the SNAP trial website: www.doherty.edu.au/education/research-project/snap-staphylococcus-aureus-network-adaptive-platform-trial